Simon Aoyama

Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI capabilities.

$ABSI and Generate Biomedicines say they’re using AI to conjure drugs from scratch. Documents, experts suggest otherwise

www.statnews.com/2025/02/10/a...

via @brittanytrang.bsky.social

How Oaktree's Howard Marks Spots a Market Bubble Podcast Episode · Odd Lots · 01/27/2025 · 54m

NEW ODD LOTS: We spoke with the legend Oaktree co-founder and co-chair Howard Marks about what it takes to spot a market bubble, and what to do when you're in one podcasts.apple.com/us/podcast/h...

Spurred by AI’s possibilities, Eli Lilly and Andreessen Horowitz partner on $500M venture fund Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money.

In an apparently unprecedented move, Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of the drug giant’s money. www.statnews.com/2025/01/10/e...

Thoughtful blog post on “Developing small molecules for antibody targets” t.co/45OC5UMkHJ

Using lab-grown human mini-brains, scientists find links between head trauma, herpes, and Alzheimer’s Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.

Using lab-grown human mini-brains, scientists find links between head trauma, herpes, and Alzheimer’s. Research suggests concussions could awaken latent infections in the brain and lead to dementia. www.statnews.com/2025/01/07/a...

Drug Company to Share Revenues With Indigenous People Who Donated Their Genes Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

Drug Company to Share Revenues With Indigenous People Who Donated Their Genes: Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes | The New York Times www.nytimes.com/2025/01/07/h...

Harvard Professors Leaving for Private Sector Research | Harvard Magazine Three distinguished scientists on leaving academia to advance biomedical research

What an amazing read (h/t Jeff Flier) - esp @michaelmina.bsky.social which felt especially raw. #biosky #medsky www.harvardmagazine.com/2025/01/harv...

This Stove Company Wants to Change How the World Uses Energy Podcast Episode · Odd Lots · 12/16/2024 · 52m

The stove that wants to change how the world gets electricity.

A fascinating episode recorded at the HQ of Impulse Labs, where we talked manufacturing, batteries, electricity, and got to eat a perfect steak an eggs. podcasts.apple.com/us/podcast/t...

Fluorescent Tags Are Basically Never Silent

Fluorescently labeled proteins are essential to research. But we should never forget how messed-up their behavior can be. An example from condensates:

A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them? Edward Scolnick led the development of dozens of medicines while at Merck. His current mission pits him against time and the mental illness of millions, including his son.

Since leaving his perch in Big Pharma, drug developer extraordinaire Ed Scolnick has sought to find effective treatments for mental-health conditions like bipolar disorder. One reason: He’s trying to help his son.